Michael Eric Faerm
age ~58
from San Carlos, CA
- Also known as:
-
- Michael E Faerm
- Mike Faerm
- Michael Fearm
- Mike Firm
- Phone and address:
-
1100 Walnut St, San Carlos, CA 94070
352 430-3227
Michael Faerm Phones & Addresses
- 1100 Walnut St, San Carlos, CA 94070 • 352 430-3227
- San Diego, CA
- 229 W 97Th St #5M, New York, NY 10025 • 212 280-0929
- 124 60Th St, New York, NY 10023 • 212 581-2112
- 124 W 60Th St #39A, New York, NY 10023 • 646 215-9127
- 200 W 26Th St #15C, New York, NY 10001 • 646 215-9136 • 212 215-9127 • 646 215-9127
- 200 26Th St, New York, NY 10001
- 440 E 85Th St #6, New York, NY 10028 • 212 439-9408
- 219 E 84Th St #5A, New York, NY 10028 • 212 472-4630
- Braintree, MA
- Cambridge, MA
Youtube
Mylife
Michael Faerm New York N...
view sourceReconnect with Michael Faerm of New York, NY. Find Michael and other people in your life at MyLife.
News
Endo Buys Par Pharma for $8.05 Billion Amid Deal Hunt
view source- 016 earnings, in line with other generic-drug transactions in the past few years, according to Bloomberg Intelligence. TPG will get become one of Endos top shareholders after the transaction, a vote of confidence for the drugmaker, Wells Fargo & Co. analyst Michael Faerm said in a note.
- Date: May 18, 2015
- Category: Business
- Source: Google
Endo Buying Par for $8B in Push for Generics, Higher Profit
view source- It also may increase that unit's profitability, as it "diversifies its presence in higher-value generics (and) potentially boosts growth and margins," Wells Fargo Securities LLC analyst Michael Faerm wrote to investors.
- Date: May 18, 2015
- Source: Google
Teva Pharmaceutical Industries Ltd Mulls Next Move As Mylan NV Offers $29 ...
view source- The branded business is the one of greater need because its going to be losing significant revenue from Copaxone and some other branded products, said Wells Fargo & Co. analyst Michael Faerm.
- Date: Apr 09, 2015
- Category: Business
- Source: Google
Generic Drug Maker Stops Making Cholesterol Pill
view source- In October, Ranbaxys product accounted for 43 percent of prescriptions for atorvastatin, the generic name for Lipitor, a widely used drug to lower cholesterol levels, according to an analysis by Michael Faerm, an analyst for Credit Suisse who used prescription data from the research firm IMS Healt
- Date: Nov 29, 2012
- Category: Health
- Source: Google
For US pharmaceutical industry, emerging markets represent a growing share of ...
view source- held drugmaker Actavis Group hf for 4.25 billion euros ($5.6 billion) to expand its reach in Europe and Asia. The deal gives Watson, the third-biggest generic drugmaker by revenue, access to markets in China, India and Eastern Europe, according to Michael Faerm, a Credit Suisse analyst in New York.
- Date: Jul 12, 2012
- Category: Business
- Source: Google
Teva May Get 'Free Money' Sharing Profit on Ranbaxy Sales of Lipitor Copy
view source- With Ranbaxy getting the approval and manufacturing it in-house, Tevas share of profit in the fourth quarter willpossibly be some amount less than the top end of the range,Michael Faerm and Judah C. Frommer, health-care analysts withCredit Suisse in New York, said in the report. We expect th
- Date: Dec 02, 2011
- Category: Health
- Source: Google
Get Report for Michael Eric Faerm from San Carlos, CA, age ~58